Responsible for monitoring and reporting the effectiveness and any adverse effects or side effects of
Riva pharma products on the market in the general population and in hospitals.
Riva pharma continually assesses new and emerging safety data as it becomes available and undertakes
regulatory action as appropriate. In addition to contributing to the safety profiles of existing drugs,
pharmacovigilance activities help to improve the knowledge set and contribute to the breadth of
epidemiological data.
Pharmacovigilance is therefore vital for the advancement of medical understanding, future research and
product development. Any improvements in safety or understanding will ultimately lead to
improvements in patient care.
Riva pharma encourages patients, careers and other members of the public to report suspected adverse
reactions (side effects) to us through email (pharmacovigilance@rivapharma.com )